Sex differences in acute kidney injury requiring dialysis

Sexual dimorphism is a well-recognized feature of chronic progressive kidney disease. [1‐5] Female sex is thought to play a protective role, meditated by differences in the hormonal milieu. [1‐5] Although less well appreciated, sexual dimorphism has also been established in the development of ischemic acute kidney injury (AKI). [6] Animal models have consistently shown a protective effect of female sex on the development of AKI after ischemia-reperfusion injury. [7‐19] Contrary to these experimental observations, the direction of sexual dimorphism has been reported to be reversed in AKI in humans. [20] Female sex has been identified as a risk factor in predictive models of acute kidney injury associated with cardiac surgery, aminoglycoside or radio-contrast administration, and rhabdomyolysis. [21‐24]. In addition, the commentary accompanying the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (online appendix A-F) states that female sex is among the shared susceptibility factors that confer a higher risk of AKI. [20] This conclusion is based on studies demonstrating that women are more likely than men to develop hospital-acquired AKI. [20] The guideline endorses the findings that female sex is associated with a higher risk for AKI in studies of cardiac surgery-associated AKI, contrast-induced nephropathy, and aminoglycoside nephropathy. [20] On the basis of these observations, the commentary concludes that, “contrary to most chronic kidney disease disorders, it is the female gender that carries a higher risk for AKI.” [20] However, the guideline goes on to qualify this conclusion by recognizing that males predominate in reports of AKI complicating infections with HIV, malaria, leptospirosis and other community acquired forms of AKI.

We have previously challenged the generally held consensus that female sex is an independent risk factor for cardiac surgery-associated AKI and for aminoglycoside nephrotoxicity. [6, 25] In the present study, we sought to explore the relationship between sex and hospital-associated AKI requiring renal replacement therapy in greater detail by examining this relationship in a large administrative database of over 194 million hospital encounters which is more than 3 times larger than all of the published cohorts reporting sex-stratified AKI incidence data combined.

Sexual dimorphism is a well-recognized feature of chronic progressive kidney disease disease. [1‐5] Although not well appreciated, sexual dimorphism has also been clearly established in ischemic AKI. [6] In contrast to CKD, where female sex is reno-protective, the direction of sexual dimorphism has been reported to be reversed in several specific forms of acute kidney injury in humans, including contrast-associated nephropathy, aminoglycoside nephrotoxicity and cardiac surgery-associated AKI.[20] On the basis of these observations, the KDIGO AKI guideline concludes that female sex is a risk factor for AKI. [20] This conclusion, however, was qualified by the observation that males predominate in reports of AKI complicating infections with HIV, malaria, leptospirosis and other community acquired forms of AKI.

The conclusion that female sex is an independent risk factor for cardiac surgery-associated AKI is contradicted by our previously published findings. [6] The conclusion that female sex is associated with an increased risk of aminoglycoside nephrotoxicity is primarily based on a small number of subjects studied by one group of investigators and contradicted by the findings of other investigators, including ourselves. [25] Although the incidence of contrast-induced nephropathy has frequently been found to be greater in women than in men [55, 56], it has been suggested that this association may merely reflect differences in administered contrast volume when adjusted for body surface area. [57]

In this study, we report the sex-stratified incidence of AKI-D among hospitalized patients in a large national database which is more than 3 times larger than all of the published cohorts reporting sex-stratified AKI incidence data combined. We found that males were 2.2 times more likely to develop AKI-D than females. Our data are similar to that previously reported from the United States. Hsu et al. [58] utilized the National Inpatient Sample to identify patients with dialysis-requiring AKI among 24 million hospitalizations, constituting a nationally representative sample of all hospitalizations in the United States between the years 2007 and 2009. Men were 1.9 times more likely to develop AKI-D than women. Similarly, Waiker et al. [59] utilized the same database to identify AKI-D among nearly 16 million hospitalizations between 2000 and 2003. Men were 1.9 times more likely to develop AKI-D than women. However, the National Inpatient Sample does not include patients hospitalized in Veterans Administration facilities. In this regard, Cronin et al. [60] studied a cohort of over 1.6 million predominantly male patients hospitalized in Veterans Administration facilities between 2003 and 2012 and identified those with AKI by KDIGO criteria and by dialysis procedure codes. By multivariate analysis, male sex was associated with a 1.27 higher risk of stage 1–3 AKI and a 2 fold greater risk of AKI-D. Although data on the relative incidence of AKI-D in men versus women have previously been reported from large administrative databases, the implications of these data have not been widely recognized. Under-recognition of the protective role of female gender in the development of AKI is reflected in the KDIGO Guideline on AKI. Our study is among the first reports to highlight the protective role of female gender in AKI in humans.

There is strong experimental basis to support our hypothesis that female sex is reno-protective in AKI. [5, 7‐19] We suggest that this reno-protection is mediated by effects of sex hormones on cellular processes instrumental in the pathogenesis of AKI, analogous to our suggestion that sex hormones mediate the beneficial effects of female sex on the course of chronic kidney disease. [1‐5] In experimental models of ischemic AKI, females show less severe functional renal impairment and less histologic damage after ischemia-reperfusion injury. [7‐19] Oophorectomy or testosterone administration has been shown to exert deleterious effects whereas castration or exogenous estrogen has been shown to be reno-protective. [9, 19] Numerous hypotheses have been proposed to explain these observations. [5, 9, 19] Sex-related differences in the generation of nitric oxide, in the synthesis and vascular response to endothelin-1, and in the renal hemodynamic response to angiotensin II have been demonstrated in experimental models and in human subjects. [9, 19] In addition, differences between the sexes in the inflammatory, hemodynamic and humoral response to ischemia-reperfusion injury have been observed. [5, 7, 9‐19]

We also found that non-dialysis requiring AKI was 1.53 times more likely to develop in men than in women (OR 1.53 (1.52,1.54), p < 0. 0001). However, we did not report this finding in light of concerns about the validity of using administrative codes to identify non-dialysis requiring AKI in men versus women. In this regard, Waiker et al. [61] reported that the sensitivity of administrative codes to identify a 100% change in serum creatinine level during hospital admission was significantly greater in men than in women. In contrast, numerous studies have established the high sensitivity, specificity, positive predictive value and negative predictive value of diagnostic codes to identify AKI-D in a variety of administrative databases [61‐65]. These indices generally exceeded 90%. [62] Not only do diagnostic codes used to identify AKI-D have a greater accuracy than those used to identify AKI, they are also unlikely to be subject to miscoding based on the sex of the patient. Yet the fact remains that, despite the objective basis for dialysis coding, the actual decision to initiate dialysis by the clinician is essentially a subjective one.

Taking into account this inherent subjectivity, we must first consider 2 inter-related issues before we can conclude that the relative incidence of AKI-D in men versus women reflects a genuine difference in the incidence of severe AKI. First, whether or not there are sex-related influences on the decision to forgo RRT in favor of conservative non-dialytic therapy and second, whether or not there are sex-related differences in the timing of RRT despite equivalent severity of AKI and equivalent indications for dialytic intervention. Later initiation of dialysis in women than in men would introduce the competing risk of mortality from underlying illnesses and would reduce the number of women with AKI at risk for dialysis. Both of these aforementioned factors might increase the incidence of AKI-D in men versus women in the absence of a genuine difference in the incidence of severe AKI. To address these issues, we performed a systematic review of differences between the sexes in dialysis practices in patients with AKI.

We identified 9 studies in which the decision to initiate RRT rather than pursue conservative non-dialytic management was assessed in men versus women with identical severity of AKI [28‐36]. These studies do not address the issue of whether or not the incidence of AKI-D is influenced by sex, but instead address the question of whether or not dialysis practices differ between men and women matched for identical severity of AKI. After propensity score matching of 545 patients with AKI who underwent RRT with an equal number of patients with AKI who did not undergo RRT, Wilson et al. [36] reported that dialysis was nearly twice as likely to be initiated in women compared to men. Similarly, 3 other studies found that women with AKI were more likely to receive RRT than men. In contrast, Vaara et al. [34] created a propensity score model for preemptive RRT (n = 105) versus no RRT (n = 2540) and found no difference between the sexes in the provision of RRT to patients with AKI in the absence of classical indications for dialysis. Similarly, 3 other studies found no difference between the sexes in the provision of RRT in AKI. In only one study were men more likely to undergo RRT compared to women. [28]

We identified 19 studies which assessed early versus late initiation of RRT in men versus women matched for severity of AKI. [34, 37‐54]. Again, these studies do not address the issue of whether or not the incidence of AKI-D is influenced by sex, but instead address the question of whether or not dialysis practices differ between men and women matched for identical severity of AKI. Chou et al. [41] utilized propensity scoring and logistic regression analysis in 370 patients with sepsis and AKI treated in surgical intensive care units and found that women, as compared to men, were 50% more likely to undergo early initiation of dialysis as assessed by RIFLE criteria. Four additional studies found that women initiated dialysis earlier than men. In contrast, Liu et al. [49] concluded that sex was not an independent predictor of early versus late dialysis using multivariate analysis despite the finding that male sex was associated with early initiation of RRT on univariate analysis. Twelve additional studies found no difference in the timing of RRT initiation between men and women. The remaining study by Bagshaw et al. [37] found that dialysis was initiated earlier in women with AKI than in men with AKI when serum creatinine level was used to define timing of dialytic intervention but found no difference between the sexes when other criteria were utilized. We were unable to identify any study that found than men with AKI underwent dialysis earlier than women. Thus, available data provide no evidence that men with AKI are more likely to undergo RRT or more likely to initiate RRT earlier than women with comparable severity of AKI. These data support our conclusion that the greater incidence of AKI-D in men compared to women truly reflects a difference in the incidence of severe AKI between the sexes.

Thus, our data clearly establishes an increased incidence of AKI-D in hospitalized men compared to women. Although we suggest that this difference reflects an increased incidence of severe AKI in men, alternative explanations may exist. Since dialysis is not a hard outcome, our conclusion may reflect differences in dialysis practices between the sexes; however, our systematic review did not support this contention. But the fact remains that none of the analyzed studies were specifically designed to compare dialysis practices in men versus women. Furthermore, dialysis may be initiated for reasons other than AKI severity, including refractory volume overload and intoxications. Local practices may differ and introduce bias, and dialysis practices have changed over time, although we consistently found a greater incidence of AKI-D in men in each time interval studied. Since AKI is not a disease but a heterogeneous group of disorders characterized by a reduction in renal function, all etiologies of AKI may not exhibit similar sexual dimorphism. Lastly, we cannot determine whether sexual dimorphism in hospital-associated AKI is driven by community-acquired AKI or hospital-acquired AKI, or both.

In a large national database which is more than 3 times larger than all of the published cohorts reporting sex-stratified AKI incidence data combined, men were 2.19 times more likely to develop AKI-D than women. This finding questions the generally held belief, expressed in the KDIGO Guideline for AKI, that female sex is a significant risk factor for AKI. On the contrary, and consistent with observations in animal models, male sex is associated with an increased incidence of hospital-associated AKI-D. Our study is among the first reports to highlight the protective role of female sex in AKI in humans.